Literature DB >> 5793185

Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin.

W R Bruce, B E Meeker, W E Powers, F A Valeriote.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5793185

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  15 in total

1.  Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.

Authors:  M P Rivera-Fillat; J Pallarés-Trujillo; C Domènech; M R Grau-Oliete
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

Review 2.  An assessment of massive-dose chemotherapy of malignant disease.

Authors:  D E Bergsagel
Journal:  Can Med Assoc J       Date:  1971-01-09       Impact factor: 8.262

3.  A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.

Authors:  M Kim; K B Woo; S Perry
Journal:  Ann Biomed Eng       Date:  1977-03       Impact factor: 3.934

4.  Therapy for advanced Hodgkin's disease.

Authors:  V P Choudhry
Journal:  Indian J Pediatr       Date:  1982 Nov-Dec       Impact factor: 1.967

5.  Drug-induced immunological unresponsiveness: selective inhibition of T-cell 'helper function' by cyclophosphamide in mice pretreated with phytohaemagglutinin.

Authors:  G Schwarze
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

6.  Effects of diflubenzuron and clanfenur on mouse bone marrow cells.

Authors:  V K Jenkins; H S Juneja; K Ives; S Lee; R R Perry
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850

Review 7.  Diagnostic and prognostic value of colony formation of hematopoietic progenitor cells in myeloid malignancies.

Authors:  Leopold Ohler; Klaus Geissler; Wolfgang Hinterberger
Journal:  Wien Klin Wochenschr       Date:  2003-08-14       Impact factor: 1.704

8.  Therapy of solid Walker carcinosarcoma 256 with bleomycin after synchronization with hydroxyurea.

Authors:  M Volm; J Mattern; N Weber; K Wayss
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

9.  Sponge-derived fijianolide polyketide class: further evaluation of their structural and cytotoxicity properties.

Authors:  Tyler A Johnson; Karen Tenney; Robert H Cichewicz; Brandon I Morinaka; Kimberly N White; Taro Amagata; Balanehru Subramanian; Joseph Media; Susan L Mooberry; Frederick A Valeriote; Phillip Crews
Journal:  J Med Chem       Date:  2007-07-10       Impact factor: 7.446

Review 10.  Some aspects of size-dependent differential drug response in primary and metastatic tumors.

Authors:  I Abe; M Suzuki; K Hori; S Saito; H Sato
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.